HM1 Leadership Restructure
Released
Released
Announcement PDF
19 May 2025
The Manager
ASX Market Announcements
ASX Limited
Exchange Centre
Level 4, 20 Bridge Street
Sydney NSW 2000
Dear Shareholders,
Hearts & Minds Restructure and Appointment of Richard Howes as Managing Director
The Board of Hearts and Minds Investments Limited (“HM1”; “Hearts & Minds”) has announced the
restructure of its leadership, transitioning from a full-time CEO role to a more streamlined model. As
a result, Brett Jollie will step down as CEO and Richard Howes will be appointed to a new part-time
role of Managing Director.
Richard is a globally experienced executive and director with over 30 years’ experience in the
financial services industry. His most recent executive role was as Group CEO of Challenger Limited,
an ASX-listed asset manager and retirement income provider.
Richard Howes will join HM1’s Board and executive team as its Managing Director on 1 June 2025 as
well as joining the Investment Committee and Conference Fund Manager Selection Committee.
Since joining HM1 in December 2024, Brett has undertaken a comprehensive review of the business,
identifying key opportunities to enhance HM1’s operations and strategic focus.
Under Brett’s leadership, HM1 has:
●
Conducted a thorough review of its operating model
●
Established a new dedicated investment operations function to improve operational
efficiency and expertise
●
Implemented an investment management system to automate and improve portfolio
management and oversight
These enhancements have significantly improved automation and efficiency and, together with the
broader capability in the senior HM1 team, have given the Board the opportunity to evolve its
leadership structure, replacing the full-time CEO role with a part-time Managing Director.
Brett will remain with HM1 until 30 June 2025 to oversee a smooth transition.
_____________________________________________
Hearts & Minds Investments Limited ACN 628 753 220
A: Suite 12.04A, Level 12, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 | W: HM1.com.au | E: ir@hm1.com.au
P: 1300 737 760 or +61 2 9290 9600
Chris Cuffe, Chair of HM1, commented:
On behalf of the Board, I want to sincerely thank Brett for his leadership and the significant
contributions he has made in such a short time. His efforts have strengthened HM1, identifying key
enhancements that will result in a more efficient, streamlined business with reduced operational risk.
Ironically, it is because of these improvements that we are now able to transition to a leaner
leadership structure. We greatly appreciate Brett’s impact.
We are delighted to be welcoming Richard to the team. Over his 30-year financial services career, he
has successfully managed and grown multi-billion dollar investment portfolios and investment
product businesses. I am confident that Richard will help us continue to improve our investment
offering and to grow our impact.
The Board will be working closely with Brett and Richard to ensure a smooth transition of leadership.
Brett commented:
I am grateful to the Board for the opportunity to lead HM1 and to contribute to its unique mission. In
a short time, we’ve made significant progress in strengthening the business, streamlining operations,
and positioning HM1 for the future. I’m confident that these enhancements will support the
company’s long-term success and purpose. I want to thank the Board and the HM1 team for their
support and collaboration, and I wish them the very best as they continue to add value to
shareholders and provide meaningful support to medical research.
Richard commented:
I am honored to be given the responsibility to be the Managing Director of Hearts & Minds which
represents both an extraordinary philanthropic success story and a genuine innovation in terms of its
investment proposition and process. I am excited to have the opportunity to work with HM1’s
outstanding Board and management team to build on this success and to further innovate.
About Hearts & Minds
Hearts & Minds is a unique purpose-driven investment organisation committed to the advancement
of Australian medical research. It consists of an ASX-listed investment company, Hearts & Minds
Investments Limited (HM1) and the annual Sohn Hearts & Minds conference.
HM1 was established in November 2018 with the dual objective of delivering a concentrated global
equities portfolio of the highest conviction ideas from selected fund managers, whilst also
supporting Australian medical research organisations. As of 30 April 2025, HM1 has delivered an
investment return of 13.29% over the past year and 9.98% per annum since inception, along with a
fully franked dividend yield of 5.6%. HM1 is recognised as one of Australia’s Top 30 Corporate
Philanthropists.
The Sohn Hearts & Minds Conference is Australia’s premier finance and philanthropy event, which
gathers international thought leaders, global fund managers and entertainers for an annual event
like no other. Founded in 2016, it is the exclusive Australian affiliate of the esteemed Sohn
Conference Foundation.
To learn more please visit: hm1.com.au
HM1 Investment Performance is calculated after expenses and before taxes. Inception 14 Nov 2018.
_____________________________________________
Hearts & Minds Investments Limited ACN 628 753 220
A: Suite 12.04A, Level 12, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 | W: HM1.com.au | E: ir@hm1.com.au
P: 1300 737 760 or +61 2 9290 9600
Annexure A – Summary of Key Terms of Appointment
Key Terms
Details
Commencement Date
1 June 2025
Remuneration
AUD $175,000 per annum
Equity Incentives
Nil
Termination and Notice
Either party may terminate without cause on 3 months written
notice.
This announcement was authorised for release by the Chair of the Board of Directors.
For and on behalf of the board,
Eryl Baron
Company Secretary
_____________________________________________
Hearts & Minds Investments Limited ACN 628 753 220
A: Suite 12.04A, Level 12, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 | W: HM1.com.au | E: ir@hm1.com.au
P: 1300 737 760 or +61 2 9290 9600
Share your feedback
Discover